Prior Authorization Leads to Radiation Oncology Treatment Delays, Patient Harm

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 9, 2024.

By Lori Solomon HealthDay Reporter

MONDAY, Dec. 9, 2024 -- Prior authorization delays lead to serious harm for people with cancer, according to a survey conducted by the American Society for Radiation Oncology (ASTRO).

The survey, conducted in the fall of 2024, included responses from 754 physicians from across the United States, representing both academic (47 percent) and private (51 percent) practices in different types of communities (49 percent urban; 39 percent suburban; 13 percent rural).

According to the results of the survey, nearly one-third of respondents (30 percent) say prior authorization has caused adverse events, including emergency room visits, hospitalization, or permanent disability for their patients, with 7 percent reporting that it has led or contributed to the death of a patient in their care. Almost all radiation oncologists (92 percent) say that prior authorization causes treatment delays, which are experienced by more than one-third of their patients (35 percent). One-third of physicians say prior authorization has led to approximately one in 10 patients abandoning radiation treatment. Most physicians (58 percent) say prior authorization left them unable to adhere to established guidelines, and 82 percent say prior authorization has forced them to resort to a less optimal treatment than they originally prescribed. More than nine in 10 radiation oncologists agree that prior authorization either significantly or somewhat worsens staff burnout in their clinics, with eight in 10 doctors saying the prior authorization burden has grown worse in the past three years.

"These survey findings confirm what radiation oncologists witness daily: prior authorization policies are failing people with cancer, causing avoidable delays that are dangerous and, in too many cases, deadly," Howard M. Sandler, M.D., chair of the ASTRO Board of Directors, said in a statement.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-10 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords